Chapter 23 - Demyelinating diseases of the nervous system
Questions
Define the following terms:
demyelination,
Guillain-Barre syndrome,
multiple
sclerosis,
Schwann
cell,
oligodendrocyte,
cytoalbuminologic
dissociation.
Demyelination is an inflammatory attack on myelin.
Guillain Barre syndrome is a monophasic illness characterized
by a cell-mediated immune attack on peripheral nervous system myelin.
Multiple sclerosis is a condition characterized by inflammatory,
demyelinating lesions in the central nervous system separated in space and
time.
The Schwann cell is the cell in the peripheral nervous system
that creates myelin.
The oligodendrocyte is the glial cell in the central nervous
system that creates myelin.
Cytoalbuminologic dissociation is the finding of high
protein in the cerebrospinal fluid without many (usually less than 6) white
blood cells. This is a characteristic of Guillain-Barre syndrome but is not
completely diagnostic.
23-1. What is
a good working definition of multiple sclerosis?
Answer 23-1. Multiple sclerosis is defined as multiple inflammatory white
matter lesions separated in space and time.
23-2. What causes
multiple sclerosis?
Answer 23-2. The cause is unknown although the rate is higher in certain
families and certain genetic types. It is also higher in certain locations
(particularly at higher latitudes), but where you spend your first 15 years
appears to determine risk (higher the further away from equator). There is an
immune attack on oligodendroglia, although the trigger is not clear.
23-3. Can a patient
with a single episode of demyelination be diagnosed with MS?
Answer 23-3. Single episodes cannot be diagnosed as definite multiple
sclerosis, although sometimes scans can detect evidence of prior as well as
recent events that fulfill criteria.
23-4. What are
the patterns of presentation for MS?
Answer 23-4. MS may be relapsing remitting, secondarily progressive,
primary progressive or rapidly progressive.
23-5. What are
common symptoms of MS?
Answer 23-5. Symptoms are scattered in the nervous system. They often
affect optic nerves (vision loss), dorsal columns (loss of sensation),
corticospinal tract (spastic weakness), cerebellar pathways (incoordination,
dysarthria), medial longitudinal fasciculus (double vision on lateral gaze),
spinal trigeminal tract (face numbness or pain) and control of the bladder.
Lhermitte sign consists of an electric sensation down back and/or legs with
neck flexion. This is due to irritation of cervical spinal cord sensory tracts.
23-6. Are certain
portions of the nervous system not affected by MS?
Answer 23-6. MS does not directly damage neuron cell bodies and therefore
does not result in basal ganglia symptoms. It does not result in LMN damage,
damage to cranial nerve nuclei, or damage to peripheral nerves. It also does
not produce aphasia or affect memory (until late in the condition).
23-7. What supportive
tests are there for the diagnosis of MS?
Answer 23-7. There are many supportive tests for MS (none is perfect).
MRI shows T2 and flair hyperintensities in periventricular distribution in well
over 90% of patients. Some of these lesions may be enhancing (if they happened
in the last 3 months). CSF shows oligoclonal bands and elevated IgG synthesis
in over 80% of patients. Evoked potentials that may show problems with sensory
systems that are not known from clinical exam. However, none of these (except serial
MRIs) can show whether lesions are separated in space and time.
23-8. What other
conditions can produce symptoms similar to MS?
Answer 23-8. You must rule out other conditions producing disseminated lesions
such as lupus, Lyme, HIV, sarcoidosis, neurosyphilis, B12 deficiency,
brucellosis, HTLV-1.
23-9. What is
Guillain Barre syndrome (acute inflammatory demyelinating polyradiculoneuropathy
- AIDP)?
Answer 23-9. Guillain-Barre syndrome is a monophasic demyelinating disease
affecting peripheral nerves.
23-10. What
causes Guillain-Barre syndrome?
Answer 23-10. Guillain-Barre syndrome may be triggered by certain infections. It is a
cell-mediated immune attack on nerve roots with a lymphocytic infiltration in
perivenous pattern.
23-11. What
laboratory findings are supportive of the diagnosis of Guillain-Barre syndrome?
Answer 23-11. CSF shows high protein but few white blood cells
(cytoalbuminologic dissociation).
23-12. What
is the usual clinical picture for Guillain-Barre syndrome?
Answer 23-12. Symptoms develop over days to weeks, usually resolving over
weeks to months. It often proceeds in an ascending fashion though it may even
start in the cranial nerves. It can paralyze all muscles (including
respiration) and produce autonomic nervous system instability. Reflexes are
lost early on, even in clinically unaffected muscles. Autonomic instability can
be fatal as can respiratory arrest, infection or pulmonary embolus.
Guillain-Barre syndrome does not affect central nervous system. Patients
usually recover (about 20% have residual).
23-13. What
treatments help in Guillain-Barre syndrome?
Answer 23-13. Treatment with plasmapheresis or human immune globulin
infusions may speed recovery. Steroids don't help the conditon.
23-14. What
is chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
Answer 23-14. CIDP is a
condition that has an appearance of chronic and demyelination of peripheral
nerves. It is associated with subacute weakness and sensory loss and (as
opposed to AIDP) responds to steroids and other immunosuppressives (including
plasmapheresis and human immune globulin infusion).